YARTEMLEASSURE PATIENT SUPPORT PROGRAM – Infos zur Marke Nr 1657385 (WIPO, 24.11.2021)

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke YARTEMLEASSURE PATIENT SUPPORT PROGRAM wurde als Bildmarke am 24.11.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.

Auf Amazon suchen

Logodesign (Wiener Klassifikation)

#Quadrilateralen #Briefe, die eine besondere Form des Schreibens darstellen #Andere unregelmäßige Parallelogramme, Trapezien und Vierecke, Vierecke mit einer oder mehreren abgerundeten Ecken #Quadrilaterale, die einen oder mehrere Buchstaben enthalten #Quadrilaterale mit dunklen Flächen oder Teilen von Flächen #Serie von Briefen, die verschiedene Formen des Schreibens darstellen #Buchstabenreihen in verschiedenen Dimensionen

Markendetails Letztes Update: 09. August 2023

Markenform	Bildmarke
Aktenzeichen	1657385
Länder
Basismarke	Nr. 90739907, 27. Mai 2021

Anmeldedatum	24. November 2021
Ablaufdatum	24. November 2031

Markeninhaber

Omeros Corporation

201 Elliott Avenue West
Seattle WA 98119
US

Markenvertreter

Anne H. Peck Cooley LLP

1299 Pennsylvania Avenue, Suite 700 Washington DC 20004 US

Waren und Dienstleistungen

16 Printed publications in the nature of brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support

35 Promoting awareness of patient support offerings for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); business administration of reimbursement and medical benefit information for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and their treatment; and business administrative services for medical referrals; benefits verification in the nature of insurance claims administration

36 Providing a website featuring financial information regarding medical benefits and reimbursements available for medical expenses related thereto (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); and insurance services; providing online information and financial assistance with insurance benefits and coverage for health care providers and patients in the field of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders

41 Educational services, namely, conducting educational programs in the fields of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and treatment and patient support options for these conditions

Übersetzung anzeigen

Markenhistorie

Datum	Belegnummer	Bereich	Eintrag
07. August 2023	2023/32 Gaz	CA	Ablehnung
21. September 2022	2022/40 Gaz	EM	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
06. August 2022	2022/33 Gaz	NZ	Ablehnung
08. Juli 2022	2022/29 Gaz	EM	Ablehnung
28. April 2022	2022/18 Gaz	AU	Ablehnung
24. November 2021	2022/14 Gaz	US	Eintragung